Spectral Medical Inc.
EDTXF
Rank in Stocks
#16163
Spectral Medical Inc. focuses on the development and commercialization of... Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal and polyclonal antibodies, recombinant cardiac proteins, antibodies, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.
Share Price
$0.77099
Last synced: 2026-11-09
Market Cap
$224.51M
Change (1 day)
12.88%
Change (1 year)
-28.61%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Spectral Medical Inc. (EDTXF)
Category
Healthcare
EPS for Spectral Medical Inc. (EDTXF)
EPS as of June 2026 TTM: $-0.09
According to Spectral Medical Inc.'s latest financial reports, its current EPS (TTM) is $-0.09. At the end of 2025 the company had an EPS of $-0.12, a decrease compared to its 2024 EPS of $-0.04.
EPS history for Spectral Medical Inc. from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.09 | -22.58% |
| 2025 | $-0.12 | 204.44% |
| 2024 | $-0.04 | -9.67% |
| 2023 | $-0.04 | 38.11% |
| 2022 | $-0.03 | 11.64% |
| 2021 | $-0.03 | -10.42% |
| 2020 | $-0.03 | 86.06% |
| 2019 | $-0.02 | 98.80% |
| 2018 | $-0.01 | -45.03% |
| 2017 | $-0.02 | -59.08% |
| 2016 | $-0.04 | 1.10% |
| 2015 | $-0.04 | -30.87% |
| 2014 | $-0.05 | -36.31% |
| 2013 | $-0.08 | 9.95% |
| 2012 | $-0.08 | 4.29% |
| 2011 | $-0.07 | -26.22% |
| 2010 | $-0.10 | -6.58% |
| 2009 | $-0.10 | 105.28% |
| 2008 | $-0.05 | -27.00% |
| 2007 | $-0.07 | -150.69% |
| 2006 | $0.14 | -141.81% |
| 2005 | $-0.33 | 232.63% |
| 2004 | $-0.10 | -52.92% |
| 2003 | $-0.21 | -15.91% |
| 2002 | $-0.25 | -20.98% |
| 2001 | $-0.32 | -40.15% |
| 2000 | $-0.53 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $18.99 | -20,541.33% |
US
|
|
| $6.12 | -6,687.73% |
US
|
|
| $1.38 | -1,582.35% |
CN
|
|
| $14.83 | -16,063.40% |
US
|
|
| $5.09 | -5,579.01% |
US
|
Questions about Spectral Medical Inc.'s earnings per share (EPS)
What is Spectral Medical Inc.'s earnings per share (EPS)?
Spectral Medical Inc.'s earnings per share (EPS) over the last twelve months is $-0.09, as of Jun 2026.
What was Spectral Medical Inc.'s earnings per share (EPS) in 2025?
In 2025, Spectral Medical Inc.'s earnings per share (EPS) was $-0.12, compared with $-0.04 in 2024.
How has Spectral Medical Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Spectral Medical Inc.'s earnings per share (EPS) was highest in 2022 ($-0.03) and lowest in 2025 ($-0.12).
How does Spectral Medical Inc.'s earnings per share (EPS) compare with similar companies?
Spectral Medical Inc.'s earnings per share (EPS) ($-0.09) is lower than that of all 5 similar companies listed above. The highest among them is Thermo Fisher Scientific Inc., with $18.99.